Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update

NEXT STORY
Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
PREV STORY
Chembio Diagnostics Attains CE Marking for DPP COVID-19 System for IgG and IgM Antibodies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Iovance Biotherapeutics Announces FDA Fast Track Designation for LN-144 for Treatment of Advanced Melanoma

SAN CARLOS, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a ...

author_avatar
NASDAQ Market News

BeiGene Announces Pricing of $750 Million Public Offering

CAMBRIDGE, Mass. and BEIJING, China, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

author_avatar
NASDAQ Market News

Morehouse Healthcare Expands Practice to Include Bariatric and Minimally Invasive Surgeries

ATLANTA, May 9, 2016 (GLOBE NEWSWIRE) -- The clinical service arm for Morehouse School ...

author_avatar
NASDAQ Market News